{
    "organizations": [],
    "uuid": "7a896eac054c4ad138cf38f3d16da0ffe38ca21b",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-catalyst-pharmaceuticals-announces/brief-catalyst-pharmaceuticals-announces-enrollment-of-first-patient-in-phase-3-trial-of-firdapse-in-musk-antibody-positive-myasthenia-gravis-idUSASC09WHA",
    "ord_in_thread": 0,
    "title": "BRIEF-Catalyst Pharmaceuticals Announces Enrollment Of First Patient In Phase 3 Trial Of Firdapse In Musk Antibody Positive Myasthenia Gravis",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 19 (Reuters) - Catalyst Pharmaceuticals Inc:\n* CATALYST PHARMACEUTICALS ANNOUNCES ENROLLMENT OF FIRST PATIENT IN PHASE 3 TRIAL OF FIRDAPSEÂ® IN MUSK ANTIBODY POSITIVE MYASTHENIA GRAVIS Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-19T20:17:00.000+03:00",
    "crawled": "2018-04-19T15:20:14.001+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "catalyst",
        "pharmaceutical",
        "inc",
        "catalyst",
        "pharmaceutical",
        "announces",
        "enrollment",
        "first",
        "patient",
        "phase",
        "trial",
        "musk",
        "antibody",
        "positive",
        "myasthenia",
        "gravis",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}